Presentation Title
A-1 Benzothiazoles as Novel Hybrid Anti-Invasion Agent Against Glioblastoma
Presenter Status
Graduate Student, Andrews University
Second Presenter Status
Instructor, Andrews University
Third Presenter Status
Associate Professor, Andrews University
Preferred Session
Oral Session
Start Date
26-10-2018 3:00 PM
End Date
26-10-2018 3:15 PM
Presentation Abstract
This presentation discusses the progress we are making regarding the efficacy of our novel synthesized hybrid benzothiazole compounds against a rare and extremely lethal brain cancer called glioblastoma. This cancer, for which there is currently no effective treatment, has been in the news recently as the cause of death for former U.S. Senator John McCain. The presentation will cover the purpose, design, and strategy of the project and the work that has been accomplished to date.
A-1 Benzothiazoles as Novel Hybrid Anti-Invasion Agent Against Glioblastoma
This presentation discusses the progress we are making regarding the efficacy of our novel synthesized hybrid benzothiazole compounds against a rare and extremely lethal brain cancer called glioblastoma. This cancer, for which there is currently no effective treatment, has been in the news recently as the cause of death for former U.S. Senator John McCain. The presentation will cover the purpose, design, and strategy of the project and the work that has been accomplished to date.
Acknowledgments
Andrews University Department Biology/Chemistry and Biochemistry, Andrews University Faculty Grants, Andrews University Graduate Student Grants in Aid of Research